{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1164.26","meta":{"versionId":"9","lastUpdated":"2021-04-29T01:00:16.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1164.26","version":"20210429","name":"Dental indications surrounding administration of medications to treat osteoporosis in men","status":"active","date":"2021-04-29T01:00:16-04:00","publisher":"LUGPA Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","concept":[{"code":"M87.180","display":"Osteonecrosis due to drugs, jaw"}]}]},"expansion":{"identifier":"urn:uuid:978239a7-abef-4dca-845a-7dab4fdb141b","timestamp":"2022-06-10T06:53:18-04:00","total":1,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://hl7.org/fhir/sid/icd-10-cm","version":"2022","code":"M87.180","display":"Osteonecrosis due to drugs, jaw"}]}}